The Food and Drug Administration on Wednesday launched a challenge to industry to develop medical devices, including digital health technologies and diagnostic tests, in an effort to combat the nationwide opioid epidemic by targeting the problems of pain, addiction, and diversion.
“Medical devices, including digital health devices like mobile medical apps, have the potential to play a unique and important role in tackling the opioid crisis,” said Scott Gottlieb, MD, commissioner of the FDA. “We must advance new ways to find tools to help address the human and financial toll of opioid addiction.”
